Mucocutaneous Lymph Node Syndrome
"Mucocutaneous Lymph Node Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
| Descriptor ID |
D009080
|
| MeSH Number(s) |
C14.907.940.560 C15.604.560 C17.800.862.560
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mucocutaneous Lymph Node Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Mucocutaneous Lymph Node Syndrome".
This graph shows the total number of publications written about "Mucocutaneous Lymph Node Syndrome" by people in this website by year, and whether "Mucocutaneous Lymph Node Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2007 | 3 | 0 | 3 |
| 2008 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mucocutaneous Lymph Node Syndrome" by people in Profiles.
-
Assessing Health Care Utilization and Compliance in Kawasaki Disease. J Pediatr. 2021 Jul; 234:181-186.e1.
-
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment. Hosp Pediatr. 2021 01; 11(1):88-93.
-
Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry. J Am Heart Assoc. 2020 08 04; 9(15):e016440.
-
Autologous Patch Angioplasty of a Giant Right Coronary Artery Aneurysm and Coronary Stenosis in Kawasaki Disease. World J Pediatr Congenit Heart Surg. 2019 05; 10(3):351-354.
-
Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease. Biomech Model Mechanobiol. 2014 Nov; 13(6):1261-76.
-
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011 May; 158(5):831-835.e3.
-
Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr. 2009 Apr; 154(4):592-595.e2.
-
Giant Kawasaki coronary artery aneurysm: cardiac imaging evolution. Eur Heart J. 2008 Dec; 29(24):3042.
-
Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007 Dec; 120(6):e1434-40.
-
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007 Jul 10; 116(2):174-9.